The period spent building up Cell Impact's capacity and capabilities in 2022-2024, has given the company a position that is unique in three ways. Cell Impact Forming™ is a patented forming technology that is scalable, resource-efficient and cost-effective, and can produce a high-quality flow plate in seconds. The Karlskoga facility is ready for high-volume manufacturing and has already delivered millions of flow plates.

"In addition to that, we also have a flexible business model that allows us to either produce flow plates at our factory or to quickly establish production lines near our customers," said Daniel Vallin, CEO of Cell Impact.

Although Cell Impact is ready for high-volume manufacturing, the market has not developed as quickly as the company had hoped. The savings programs were effective, and current operations are now well adapted. Also, activity levels at the company remain high, in terms of sales as well as customer projects.

"However, the order volume fell short of our expectations for the fourth quarter. We see this trend continuing into the beginning of the first quarter of 2025, although our full-year outlook remains unchanged at this time. If the trend of lower-than-expected order intake continues, the company will most likely need additional financing, which is not yet secured as of today," concluded Daniel Vallin.

Financial summary

• Net sales totaled SEK 2.2 million (0.8).
• Operating loss (EBIT) was SEK -39.7 million (-38.8).
• The Group's result after financial items was SEK -38.9 million (-37.5).
• Earnings per share attributable to the Parent Company's shareholders before and after dilution totaled SEK -0.06 (-0.18).
• Debt/equity ratio was 84 percent (79) on the balance sheet date.
• Cash flows from operating activities amounted to SEK -7.9 million (-25.6).
• On the balance sheet date, the Group's cash and cash equivalents totaled SEK 20.4 million (99.9).
• On February 13, the company's cash and cash equivalents amounted to SEK 15,1 million.
• In the quarter, the income statement was charged with impairment and disposals of equipment totaling SEK -15.9 million (-5.2).

This information is inside information that Cell Impact AB is obliged to make public pursuant to the EU Market Abuse Regulation.